All News

A pharmacy owner facing an indictment charging her with submitting millions of dollars in fraudulent claims to Medicare and Medicaid is expected to be arraigned today in federal court in Brooklyn, New York.

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

A mobile app technology used to identify and track symptom relief helped measure real-time cannabis use.

Diets high in foods such as vegetables, fruit, and healthy fats found to lower the risk of death from all causes, cardiovascular disease, and cancer.

The American Hospital Association (AHA) and individual hospitals have initiated new principles for ensuring good stewardship of the 340B drug program.

A federal appropriations bill will not include bipartisan provision that would have required drug manufacturers to be more transparent with costs to consumers after it was blocked by House Republicans.

What's the best advice for a patient who is interested in a vaccine against shingles?

A coalition of health care industry leaders hosted a meeting Thursday in Washington, DC, to examine how to address this problem.

Mylan’s new Dalfampridine Extended-Release Tablets, 10 mg, an authorized generic version of Acorda's Ampyra® is being marketed to treat adult patients with multiple sclerosis.

A new report has found mortality rates for 5 of the 12 leading causes of death in the United States have increased since 2000.

A national survey demonstrated gaps in medical providers’ knowledge about changes to HIV health care delivery due to the Affordable Care Act.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The FDA did not identify any new or unexpected safety findings with pimavanserin (Nuplazid), nor findings that are inconsistent with the established safety profile currently described in the drug label, in an analysis of all available data.

Top news of the week from Specialty Pharmacy Times.

Health, United States, 2017 includes an in-depth special feature that discusses mortality in America.

The FDA did not identify any new or unexpected safety findings with pimavanserin (Nuplazid), nor findings that are inconsistent with the established safety profile currently described in the drug label.

The social media post noted that grief counselors will be made available to associates and "will remain available as long as they are needed."

The FDA did not identify any new or unexpected safety findings with pimavanserin (Nuplazid), nor findings that are inconsistent with the established safety profile currently described in the drug label, in an analysis of all available data.

In this clip, Troy Trygstad, Editor in Chief of Pharmacy Times, interviews Jack Vallandinham, the owner of Jack’s Corner Drug Store in Sigourney, Iowa. Jack explains how he works with other health care providers and gets to know patient needs in order to provide them with optimal care.

In 2016, 5 million deaths in low- and middle-income countries (LMICs) were estimated to be due to poor-quality health care.

Phase 3 trial results for dupilumab (Dupixent) demonstrate improvement in skin clearing, itch, and certain quality of life measurements for adolescents with atopic dermatitis.

The phase 3 PARADIGMS clinical trial is the first-ever study designed for children and adolescents aged 10 to 17 years old with relapsing forms of multiple sclerosis.

Top news of the day from across the health care landscape.

A global phase 3a trial successfully demonstrated greater reductions in HbA1c and body weight with a oral semaglutide drug treatment than with dulaglutide, as well as a a comparable number of adverse events in 458 Japanese adults with type 2 diabetes between these medications.

Top news of the day from across the health care landscape.

Patients with multiple sclerosis incur higher costs and experience lower health-related quality of life as their disability increases

Pharmacy gag clauses forbid pharmacists from proactively telling consumers if their prescription would cost less if they paid for it out-of-pocket rather than using their insurance plan.

Implementation of universal health care is part of the Sustainable Development Goals (SDGs), which are new targets signed by 193 United Nations member states to improve health and development by 2030.

The American Hospital Association and individual hospitals have initiated new principles for ensuring good stewardship of the 340B drug program.